Guidelines | British Society for Haematology

Guidelines with addenda only

Good Practice Papers

Position Papers

Audio & written commentary

Switch between grid and list views

Guideline

Haemato-oncology

Guideline for the treatment of chronic lymphocytic leukaemia

Published:

21/03/2022

Further details

Guideline

Haemato-oncology

Guidelines for the management of mature T- and natural killer-cell lymphomas (excluding cutaneous T-cell lymphoma)

Published:

23/11/2021

Further details

Good Practice Paper

Haemato-oncology

GPP Richter transformation of chronic lymphocytic leukaemia

Published:

04/10/2021

Further details

Good Practice Paper

Haemato-oncology

GPP Management of cardiovascular complications of bruton tyrosine kinase inhibitors

Published:

08/09/2021

Further details

Good Practice Paper

General Haematology

GPP Use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders

Published:

18/08/2021

Further details

Guideline

Haemato-oncology

Guidelines on the diagnosis, investigation and initial treatment of myeloma

Published:

21/03/2021

Further details

Guideline

Haemato-oncology

Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V)

Published:

14/10/2020

Further details

Guideline

Haemato-oncology

Guideline on the diagnosis and management of chronic myeloid leukaemia

Published:

30/07/2020

Further details

Guideline

General Haematology

Investigation and management of Transient Leukaemia of Down Syndrome

Published:

19/06/2018

Further details

Guideline

Haemostasis and Thrombosis

Management of Thrombotic and Haemostatic issues in Paediatric Malignancy

Published:

31/01/2018

Further details

Guideline

Haemato-oncology

Haemato-oncology

Investigation and Management of Eosinophilia

Published:

01/08/2016

Further details

Guideline

Haemato-oncology

Management of AML in Pregnancy

Published:

17/06/2015

Further details

1 2